Page 84 - Read Online

Page 10 of 10 Grynkiewicz. J Cancer Metastasis Treat 2020;6:48 I http://dx.doi.org/10.20517/2394-4722.2020.112

health. Crit Rev Food Sci Nutr 2016;57:1280-93.
61. Xiao, CW. Health effects of soy protein and isoflavones in humans J Nutr 2008;138:1244S-9.
62. Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res 2003;17:845-69.
63. Hooper L, Ryder J, Kurzer M, et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-
menopausal women: a systematic review and meta-analysis. Hum Reprod Update 2009;15:423-40.
64. Douglas C, Johnson S, Arjmandi B. Soy and its isoflavones: the truth behind the science in breast cancer. Anticancer Agents Med Chem
2013;13:1178-87.
65. Chae HS, Xu R, Won JY, Chin YW, Yim H. Molecular targets of genistein and its related flavonoids to exert anticancer effects. Int J Mol
Sci 2019;20:2420.
66. Sacks FM, Lichtenstein A, Van Horn L, et al. Soy protein, isoflavones, and cardiovascular health. Circulation 2006;113:1034-44.
67. Ullmann U, Bendik I, Flühmann B. Bonistein (synthetic genistein) a food component in development for a bone health nutraceutical. J
Physiol Pharmacol 2005;56:79-95.
68. Křížová L, Dadáková K, Kašparovská J, Kašparovský T. Isoflavones. Molecules 2019;24:1076.
69. Jian L. Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 2009;53:217-26.
70. Banecka-Majkutewicz Z, Jakóbkiewicz-Banecka J, Gabig-Cimińska M, Węgrzyn A, Węgrzyn G. Putative biological mechanism of
efficiency of substrate reduction therapies for mucopolisaccharidoses. Arch Immunol Ther Exp 2012;60:461-8.
71. Ferrari SM, Antonelli A, Guidi P, et al. Genotoxicity evaluation of the soybean isoflavone genistein in human papillary thyroid cancer
cells. Study of its potential use in thyroid cancer therapy. Nutr Cancer 2019;71:1335-44.
72. Rusin A, Krawczyk Z, Grynkiewicz G, et al. Synthetic derivatives of genistein, their properties and possible applications. Acta Biochim
Polon 2010;57:23-34.
73. Landauer MR, Harvey AJ, Kaytor MD, Day RM. Mechanism and therapeutic window of genistein nanosuspension to protect against
hematopoietic-acute radiation syndrome. J Rad Res 2019;2019:308-17.
74. Singh VK, Seed TM. Bio 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the
delayed effects of acute radiation exposure. Exp Opin Investig Drugs 2020;29:429-41.
75. Cheema AK, Mehta KI, Santiago PT, et al. Pharmacokinetic and metabolomics studies with BIO 300, a nanosuspension of genistein in a
nonhuman primate model. Int J Mol Sci 2019;20:1231.